Organ-on-chip & MPSconfirmed

Quris-AI

Bio-AI platform that trains clinical safety prediction models on stem cell-derived patients-on-a-chip.

Notable

Acquired kidney-on-chip developer Nortis (Oct 2024). Merck KGaA uses its platform for preclinical small-molecule safety.

Jan 7, 2025
Partnership
Merck KGaA integrated Quris-AI's platform for preclinical small-molecule safety evaluation.
Undisclosed
owler.com(opens in new tab)

No related news yet.